SEC Form 4 · accession 0001567619-19-005560
RESMED INC · RMD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Robert Andrew Douglas
Officer — President and COO ResMed Inc.
Period of report
Feb 27, 2019
Accepted (ET)
Feb 28, 2019 · 1:30 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000943819
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| ResMed Common Stock | Feb 27, 2019 | M | 6,876 | $43.63 | A | 45,297 | D | |
| ResMed Common Stock | holding | — | — | — | 154,326 | I | Douglas Family Trust |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ResMed Common Stock OptionsF1 | $43.63 | Feb 27, 2019 | M | 6,876 | D | Mar 1, 2014 | Mar 1, 2020 | ResMed Commmon Stock | 6,876 | 0 | D |
Explanation of responses
- F1Represents date options first became exercisable. Options vest 1/3 per year.